The incorporation of TPGS in R19-loaded NPs enhanced its antiproliferative and proapoptotic activity in both hormone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cell lines. The gene discussed is NR4A1; the disease is breast cancer.